Canaccord Genuity Maintains Buy on Axogen, Raises Price Target to $60

Benzinga · 1d ago
Canaccord Genuity analyst Caitlin Roberts maintains Axogen (NASDAQ:AXGN) with a Buy and raises the price target from $55 to $60.